House Approves 2009 Intelligence Bill Despite Veto Threat
The House of Representatives yesterday overwhelmingly approved its version of the Fiscal Year 2009 intelligence authorization act, including new requirements that the executive branch provide more complete briefings for all members of the intelligence oversight committees. The White House threatened a veto if that and other provisions were enacted.
“This bill is about ensuring the proper oversight of our nation’s intelligence agencies and that the administration complies with the law requiring Congress be kept fully and currently informed,” said Rep. Pete Hoekstra (R-MI). “There may be concerns with the bill, but I am not sure they rise to the veto level unless the objection is to proper oversight.”
“I am very glad that 75 percent of the dollars for covert action have been fenced [until reporting requirements are fulfilled],” said Rep. Anna Eshoo (D-CA). “In other words, no notification from the administration and from the intelligence community, no money. And that’s the way it should be.”
“As someone who sat through countless hours of Intelligence Committee hearings and briefings, I have been appalled by the unwillingness and outright stonewalling of the Bush Administration when Members have asked even the most basic of questions about our intelligence community policies and practices,” said Rep. Alcee L. Hastings (D-FL).
“I think it would be sufficient to say that this administration has taken a cavalier attitude toward its legal obligations to keep the committees fully and currently informed,” said Rep. Rush Holt (D-NJ).
The floor debate also addressed funding for space surveillance systems, said by some to be inadequate, and the role of contractors in intelligence activities.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.